Behbodikhah, J.; Ahmed, S.; Elyasi, A.; Kasselman, L.J.; De Leon, J.; Glass, A.D.; Reiss, A.B.
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. Metabolites 2021, 11, 690.
https://doi.org/10.3390/metabo11100690
AMA Style
Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, Glass AD, Reiss AB.
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. Metabolites. 2021; 11(10):690.
https://doi.org/10.3390/metabo11100690
Chicago/Turabian Style
Behbodikhah, Jennifer, Saba Ahmed, Ailin Elyasi, Lora J. Kasselman, Joshua De Leon, Amy D. Glass, and Allison B. Reiss.
2021. "Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target" Metabolites 11, no. 10: 690.
https://doi.org/10.3390/metabo11100690
APA Style
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., De Leon, J., Glass, A. D., & Reiss, A. B.
(2021). Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. Metabolites, 11(10), 690.
https://doi.org/10.3390/metabo11100690